710 related articles for article (PubMed ID: 17200412)
21. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.
Brunkow ME; Jeffery EW; Hjerrild KA; Paeper B; Clark LB; Yasayko SA; Wilkinson JE; Galas D; Ziegler SF; Ramsdell F
Nat Genet; 2001 Jan; 27(1):68-73. PubMed ID: 11138001
[TBL] [Abstract][Full Text] [Related]
22. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice.
Kim JM; Rasmussen JP; Rudensky AY
Nat Immunol; 2007 Feb; 8(2):191-7. PubMed ID: 17136045
[TBL] [Abstract][Full Text] [Related]
23. Role of CD28 in fatal autoimmune disorder in scurfy mice.
Singh N; Chandler PR; Seki Y; Baban B; Takezaki M; Kahler DJ; Munn DH; Larsen CP; Mellor AL; Iwashima M
Blood; 2007 Aug; 110(4):1199-206. PubMed ID: 17463170
[TBL] [Abstract][Full Text] [Related]
24. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
25. TGF-beta-induced Foxp3+ regulatory T cells rescue scurfy mice.
Huter EN; Punkosdy GA; Glass DD; Cheng LI; Ward JM; Shevach EM
Eur J Immunol; 2008 Jul; 38(7):1814-21. PubMed ID: 18546144
[TBL] [Abstract][Full Text] [Related]
26. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
Williams LM; Rudensky AY
Nat Immunol; 2007 Mar; 8(3):277-84. PubMed ID: 17220892
[TBL] [Abstract][Full Text] [Related]
27. Transient Depletion of Foxp3
Watts D; Janßen M; Jaykar M; Palmucci F; Weigelt M; Petzold C; Hommel A; Sparwasser T; Bonifacio E; Kretschmer K
Front Immunol; 2021; 12():720133. PubMed ID: 34447385
[TBL] [Abstract][Full Text] [Related]
28. Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects.
Muramatsu K; Ujiie H; Kobayashi I; Nishie W; Izumi K; Ito T; Yoshimoto N; Natsuga K; Iwata H; Shimizu H
J Allergy Clin Immunol; 2018 Dec; 142(6):1818-1830.e6. PubMed ID: 29704593
[TBL] [Abstract][Full Text] [Related]
29. A function for interleukin 2 in Foxp3-expressing regulatory T cells.
Fontenot JD; Rasmussen JP; Gavin MA; Rudensky AY
Nat Immunol; 2005 Nov; 6(11):1142-51. PubMed ID: 16227984
[TBL] [Abstract][Full Text] [Related]
30. In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity.
Loser K; Hansen W; Apelt J; Balkow S; Buer J; Beissert S
Gene Ther; 2005 Sep; 12(17):1294-304. PubMed ID: 15973443
[TBL] [Abstract][Full Text] [Related]
31. Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice.
Kim J; Lahl K; Hori S; Loddenkemper C; Chaudhry A; deRoos P; Rudensky A; Sparwasser T
J Immunol; 2009 Dec; 183(12):7631-4. PubMed ID: 19923467
[TBL] [Abstract][Full Text] [Related]
32. Deacetylase inhibition promotes the generation and function of regulatory T cells.
Tao R; de Zoeten EF; Ozkaynak E; Chen C; Wang L; Porrett PM; Li B; Turka LA; Olson EN; Greene MI; Wells AD; Hancock WW
Nat Med; 2007 Nov; 13(11):1299-307. PubMed ID: 17922010
[TBL] [Abstract][Full Text] [Related]
33. IPEX and FOXP3: clinical and research perspectives.
Wildin RS; Freitas A
J Autoimmun; 2005; 25 Suppl():56-62. PubMed ID: 16243487
[TBL] [Abstract][Full Text] [Related]
34. Forkhead box protein 3: essential immune regulatory role.
Nik Tavakoli N; Hambly BD; Sullivan DR; Bao S
Int J Biochem Cell Biol; 2008; 40(11):2369-73. PubMed ID: 18037337
[TBL] [Abstract][Full Text] [Related]
35. Functional stability of Foxp3+ regulatory T cells.
da Silva Martins M; Piccirillo CA
Trends Mol Med; 2012 Aug; 18(8):454-62. PubMed ID: 22771168
[TBL] [Abstract][Full Text] [Related]
36. Transplantation of T cell-mediated, lymphoreticular disease from the scurfy (sf) mouse.
Godfrey VL; Rouse BT; Wilkinson JE
Am J Pathol; 1994 Aug; 145(2):281-6. PubMed ID: 8053488
[TBL] [Abstract][Full Text] [Related]
37. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT
Nat Immunol; 2007 Sep; 8(9):931-41. PubMed ID: 17694059
[TBL] [Abstract][Full Text] [Related]
38. CCR7 with S1P1 signaling through AP-1 for migration of Foxp3+ regulatory T-cells controls autoimmune exocrinopathy.
Ishimaru N; Yamada A; Nitta T; Arakaki R; Lipp M; Takahama Y; Hayashi Y
Am J Pathol; 2012 Jan; 180(1):199-208. PubMed ID: 22067914
[TBL] [Abstract][Full Text] [Related]
39. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes.
Chen Z; Herman AE; Matos M; Mathis D; Benoist C
J Exp Med; 2005 Nov; 202(10):1387-97. PubMed ID: 16301745
[TBL] [Abstract][Full Text] [Related]
40. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
